Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 ANG-3070 1.4.3 CIM-2 1.4.4 CR-8 1.4.5 Others 1.5 Market by Application 1.5.1 Global Polycystic Kidney Disease Treatment Market Share by Application: 2020 VS 2026 1.5.2 Clinic 1.5.3 Research Center 1.5.4 Hospital 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Polycystic Kidney Disease Treatment Market Perspective (2015-2026) 2.2 Polycystic Kidney Disease Treatment Growth Trends by Regions 2.2.1 Polycystic Kidney Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Polycystic Kidney Disease Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Polycystic Kidney Disease Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Polycystic Kidney Disease Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Polycystic Kidney Disease Treatment Players by Market Size 3.1.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue (2015-2020) 3.1.2 Global Polycystic Kidney Disease Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Polycystic Kidney Disease Treatment Market Concentration Ratio 3.2.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2019 3.3 Polycystic Kidney Disease Treatment Key Players Head office and Area Served 3.4 Key Players Polycystic Kidney Disease Treatment Product Solution and Service 3.5 Date of Enter into Polycystic Kidney Disease Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Type (2015-2020) 4.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2021-2026) 5 Polycystic Kidney Disease Treatment Breakdown Data by Application (2015-2026) 5.1 Global Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Polycystic Kidney Disease Treatment Market Size (2015-2020) 6.2 Polycystic Kidney Disease Treatment Key Players in North America (2019-2020) 6.3 North America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 6.4 North America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Polycystic Kidney Disease Treatment Market Size (2015-2020) 7.2 Polycystic Kidney Disease Treatment Key Players in Europe (2019-2020) 7.3 Europe Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 7.4 Europe Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 8 China 8.1 China Polycystic Kidney Disease Treatment Market Size (2015-2020) 8.2 Polycystic Kidney Disease Treatment Key Players in China (2019-2020) 8.3 China Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 8.4 China Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Polycystic Kidney Disease Treatment Market Size (2015-2020) 9.2 Polycystic Kidney Disease Treatment Key Players in Japan (2019-2020) 9.3 Japan Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 9.4 Japan Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Polycystic Kidney Disease Treatment Market Size (2015-2020) 10.2 Polycystic Kidney Disease Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 11 India 11.1 India Polycystic Kidney Disease Treatment Market Size (2015-2020) 11.2 Polycystic Kidney Disease Treatment Key Players in India (2019-2020) 11.3 India Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 11.4 India Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Polycystic Kidney Disease Treatment Market Size (2015-2020) 12.2 Polycystic Kidney Disease Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) 12.4 Central & South America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Angion Biomedica Corp 13.1.1 Angion Biomedica Corp Company Details 13.1.2 Angion Biomedica Corp Business Overview and Its Total Revenue 13.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Introduction 13.1.4 Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)) 13.1.5 Angion Biomedica Corp Recent Development 13.2 Aptevo Therapeutics Inc 13.2.1 Aptevo Therapeutics Inc Company Details 13.2.2 Aptevo Therapeutics Inc Business Overview and Its Total Revenue 13.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Introduction 13.2.4 Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.2.5 Aptevo Therapeutics Inc Recent Development 13.3 Celgene Corp 13.3.1 Celgene Corp Company Details 13.3.2 Celgene Corp Business Overview and Its Total Revenue 13.3.3 Celgene Corp Polycystic Kidney Disease Treatment Introduction 13.3.4 Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.3.5 Celgene Corp Recent Development 13.4 Conatus Pharmaceuticals Inc 13.4.1 Conatus Pharmaceuticals Inc Company Details 13.4.2 Conatus Pharmaceuticals Inc Business Overview and Its Total Revenue 13.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Introduction 13.4.4 Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.4.5 Conatus Pharmaceuticals Inc Recent Development 13.5 DiscoveryBiomed Inc 13.5.1 DiscoveryBiomed Inc Company Details 13.5.2 DiscoveryBiomed Inc Business Overview and Its Total Revenue 13.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Introduction 13.5.4 DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.5.5 DiscoveryBiomed Inc Recent Development 13.6 Endocyte Inc 13.6.1 Endocyte Inc Company Details 13.6.2 Endocyte Inc Business Overview and Its Total Revenue 13.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Introduction 13.6.4 Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.6.5 Endocyte Inc Recent Development 13.7 IC-MedTech Inc 13.7.1 IC-MedTech Inc Company Details 13.7.2 IC-MedTech Inc Business Overview and Its Total Revenue 13.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Introduction 13.7.4 IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.7.5 IC-MedTech Inc Recent Development 13.8 Ipsen SA 13.8.1 Ipsen SA Company Details 13.8.2 Ipsen SA Business Overview and Its Total Revenue 13.8.3 Ipsen SA Polycystic Kidney Disease Treatment Introduction 13.8.4 Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.8.5 Ipsen SA Recent Development 13.9 Kadmon Corp LLC 13.9.1 Kadmon Corp LLC Company Details 13.9.2 Kadmon Corp LLC Business Overview and Its Total Revenue 13.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Introduction 13.9.4 Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.9.5 Kadmon Corp LLC Recent Development 13.10 Madrigal Pharmaceuticals Inc. 13.10.1 Madrigal Pharmaceuticals Inc. Company Details 13.10.2 Madrigal Pharmaceuticals Inc. Business Overview and Its Total Revenue 13.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Introduction 13.10.4 Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 13.10.5 Madrigal Pharmaceuticals Inc. Recent Development 13.11 ManRos Therapeutics 10.11.1 ManRos Therapeutics Company Details 10.11.2 ManRos Therapeutics Business Overview and Its Total Revenue 10.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Introduction 10.11.4 ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 10.11.5 ManRos Therapeutics Recent Development 13.12 Metabolic Solutions Development Company LLC 10.12.1 Metabolic Solutions Development Company LLC Company Details 10.12.2 Metabolic Solutions Development Company LLC Business Overview and Its Total Revenue 10.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Introduction 10.12.4 Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 10.12.5 Metabolic Solutions Development Company LLC Recent Development 13.13 Mironid Ltd 10.13.1 Mironid Ltd Company Details 10.13.2 Mironid Ltd Business Overview and Its Total Revenue 10.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Introduction 10.13.4 Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) 10.13.5 Mironid Ltd Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Polycystic Kidney Disease Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue Table 3. Ranking of Global Top Polycystic Kidney Disease Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of ANG-3070 Table 6. Key Players of CIM-2 Table 7. Key Players of CR-8 Table 8. Key Players of Others Table 9. Global Polycystic Kidney Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Polycystic Kidney Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Polycystic Kidney Disease Treatment Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Polycystic Kidney Disease Treatment Market Share by Regions (2015-2020) Table 13. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Polycystic Kidney Disease Treatment Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Polycystic Kidney Disease Treatment Market Growth Strategy Table 19. Main Points Interviewed from Key Polycystic Kidney Disease Treatment Players Table 20. Global Polycystic Kidney Disease Treatment Revenue by Players (2015-2020) (Million US$) Table 21. Global Polycystic Kidney Disease Treatment Market Share by Players (2015-2020) Table 22. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2019) Table 23. Global Polycystic Kidney Disease Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Polycystic Kidney Disease Treatment Product Solution and Service Table 26. Date of Enter into Polycystic Kidney Disease Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 29. Global Polycystic Kidney Disease Treatment Market Size Share by Type (2015-2020) Table 30. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Polycystic Kidney Disease Treatment Market Size Share by Application (2015-2020) Table 32. Global Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 33. Global Polycystic Kidney Disease Treatment Market Size Share by Application (2021-2026) Table 34. North America Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 35. North America Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 36. North America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 37. North America Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 38. North America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 39. North America Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 40. Europe Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 42. Europe Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 43. Europe Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 44. Europe Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 45. Europe Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 46. China Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 47. China Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 48. China Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 49. China Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 50. China Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 51. China Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 52. Japan Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 54. Japan Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 55. Japan Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 56. Japan Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 57. Japan Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 60. Southeast Asia Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 62. Southeast Asia Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 64. India Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 65. India Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 66. India Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 67. India Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 68. India Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 69. India Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 70. Central & South America Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020) Table 72. Central & South America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Polycystic Kidney Disease Treatment Market Share by Type (2015-2020) Table 74. Central & South America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Polycystic Kidney Disease Treatment Market Share by Application (2015-2020) Table 76. Angion Biomedica Corp Company Details Table 77. Angion Biomedica Corp Business Overview Table 78. Angion Biomedica Corp Product Table 79. Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 80. Angion Biomedica Corp Recent Development Table 81. Aptevo Therapeutics Inc Company Details Table 82. Aptevo Therapeutics Inc Business Overview Table 83. Aptevo Therapeutics Inc Product Table 84. Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 85. Aptevo Therapeutics Inc Recent Development Table 86. Celgene Corp Company Details Table 87. Celgene Corp Business Overview Table 88. Celgene Corp Product Table 89. Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 90. Celgene Corp Recent Development Table 91. Conatus Pharmaceuticals Inc Company Details Table 92. Conatus Pharmaceuticals Inc Business Overview Table 93. Conatus Pharmaceuticals Inc Product Table 94. Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 95. Conatus Pharmaceuticals Inc Recent Development Table 96. DiscoveryBiomed Inc Company Details Table 97. DiscoveryBiomed Inc Business Overview Table 98. DiscoveryBiomed Inc Product Table 99. DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 100. DiscoveryBiomed Inc Recent Development Table 101. Endocyte Inc Company Details Table 102. Endocyte Inc Business Overview Table 103. Endocyte Inc Product Table 104. Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 105. Endocyte Inc Recent Development Table 106. IC-MedTech Inc Company Details Table 107. IC-MedTech Inc Business Overview Table 108. IC-MedTech Inc Product Table 109. IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 110. IC-MedTech Inc Recent Development Table 111. Ipsen SA Business Overview Table 112. Ipsen SA Product Table 113. Ipsen SA Company Details Table 114. Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 115. Ipsen SA Recent Development Table 116. Kadmon Corp LLC Company Details Table 117. Kadmon Corp LLC Business Overview Table 118. Kadmon Corp LLC Product Table 119. Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 120. Kadmon Corp LLC Recent Development Table 121. Madrigal Pharmaceuticals Inc. Company Details Table 122. Madrigal Pharmaceuticals Inc. Business Overview Table 123. Madrigal Pharmaceuticals Inc. Product Table 124. Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 125. Madrigal Pharmaceuticals Inc. Recent Development Table 126. ManRos Therapeutics Company Details Table 127. ManRos Therapeutics Business Overview Table 128. ManRos Therapeutics Product Table 129. ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 130. ManRos Therapeutics Recent Development Table 131. Metabolic Solutions Development Company LLC Company Details Table 132. Metabolic Solutions Development Company LLC Business Overview Table 133. Metabolic Solutions Development Company LLC Product Table 134. Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 135. Metabolic Solutions Development Company LLC Recent Development Table 136. Mironid Ltd Company Details Table 137. Mironid Ltd Business Overview Table 138. Mironid Ltd Product Table 139. Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$) Table 140. Mironid Ltd Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Polycystic Kidney Disease Treatment Market Share by Type: 2020 VS 2026 Figure 2. ANG-3070 Features Figure 3. CIM-2 Features Figure 4. CR-8 Features Figure 5. Others Features Figure 6. Global Polycystic Kidney Disease Treatment Market Share by Application: 2020 VS 2026 Figure 7. Clinic Case Studies Figure 8. Research Center Case Studies Figure 9. Hospital Case Studies Figure 10. Polycystic Kidney Disease Treatment Report Years Considered Figure 11. Global Polycystic Kidney Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Polycystic Kidney Disease Treatment Market Share by Regions: 2020 VS 2026 Figure 13. Global Polycystic Kidney Disease Treatment Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Polycystic Kidney Disease Treatment Market Share by Players in 2019 Figure 16. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2019 Figure 18. North America Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Angion Biomedica Corp Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 27. Aptevo Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 29. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 31. Conatus Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 33. DiscoveryBiomed Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 35. Endocyte Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 37. IC-MedTech Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 39. Ipsen SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 41. Kadmon Corp LLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 43. Madrigal Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 45. ManRos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 47. Metabolic Solutions Development Company LLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 49. Mironid Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Angion Biomedica Corp Aptevo Therapeutics Inc Celgene Corp Conatus Pharmaceuticals Inc DiscoveryBiomed Inc Endocyte Inc IC-MedTech Inc Ipsen SA Kadmon Corp LLC Madrigal Pharmaceuticals Inc. ManRos Therapeutics Metabolic Solutions Development Company LLC Mironid Ltd